Department of Colorectal Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Colorectal Dis. 2013 Apr;15(4):481-6. doi: 10.1111/codi.12058.
Whether bowel related dysfunction adversely affects postoperative recovery after total colectomy with ileorectal anastomosis (C + IRA) for colonic inertia (CI) has not been previously well evaluated. This study compared the early postoperative outcome of C + IRA for CI and for other noninflammatory indications.
Patients undergoing elective C + IRA from 1999 to 2010 were identified from a prospectively maintained database. Since inflammation in the rectum or small bowel may influence the outcome, patients with inflammatory bowel disease were excluded. Patients undergoing surgery for CI (group A) were compared with patients having the operation for other benign noninflammatory diseases (group B). Demographics, American Society of Anesthesiologists (ASA) score, body mass index (BMI), surgical procedure and 30-day complications were assessed.
The study population consisted of 333 patients undergoing elective C + IRA (99 men, mean age 39 ± 16 years). The procedure was laparoscopic in 163 (49%) patients. Groups A (n = 131) and B (n = 202) had similar age and ASA score (39 ± 11 vs 39 ± 19 years, P = 0.4; 2.2 ± 0.5 vs 2.4 ± 0.7). Group A patients had lower BMI (25 ± 5 vs 28 ± 8 kg/m(2) , P = 0.002), more women (99 vs 51%, P < 0.001) and fewer laparoscopic procedures (43 vs 53%, P = 0.04). Compared with group B, group A had a greater incidence of postoperative ileus (32 vs 19%, P = 0.009), higher overall morbidity (36 vs 15%, P < 0.001) and increased length of stay (8.4 ± 6 vs 7.2 ± 5 days, P < 0.006). These differences persisted when subgroups of patients who underwent laparoscopic or open surgery were compared.
Although CI is considered a 'benign' condition, patients undergoing C + IRA for this indication have significant morbidity compared with patients having the operation for other noninflammatory benign conditions.
结直肠慢传输型便秘行全结肠切除回直肠吻合术(C+IRA)后,肠道相关功能障碍是否会对术后恢复产生不利影响,这一点尚未得到很好的评估。本研究比较了 C+IRA 治疗慢传输型便秘和其他非炎症性指征的早期术后结果。
从一个前瞻性维护的数据库中确定了 1999 年至 2010 年间接受择期 C+IRA 的患者。由于直肠或小肠的炎症可能会影响结果,因此排除了炎症性肠病患者。将接受手术治疗慢传输型便秘的患者(A 组)与接受手术治疗其他良性非炎症性疾病的患者(B 组)进行比较。评估了人口统计学、美国麻醉医师协会(ASA)评分、体重指数(BMI)、手术过程和 30 天并发症。
研究人群包括 333 例接受择期 C+IRA(99 例男性,平均年龄 39±16 岁)的患者。163 例患者(49%)行腹腔镜手术。A 组(n=131)和 B 组(n=202)的年龄和 ASA 评分相似(39±11 岁 vs 39±19 岁,P=0.4;2.2±0.5 vs 2.4±0.7)。A 组患者 BMI 较低(25±5 公斤/平方米 vs 28±8 公斤/平方米,P=0.002),女性较多(99 例 vs 51%,P<0.001),腹腔镜手术较少(43 例 vs 53%,P=0.04)。与 B 组相比,A 组术后肠麻痹发生率较高(32% vs 19%,P=0.009),总发病率较高(36% vs 15%,P<0.001),住院时间较长(8.4±6 天 vs 7.2±5 天,P<0.006)。当比较行腹腔镜或开放手术的患者亚组时,这些差异仍然存在。
尽管慢传输型便秘被认为是一种“良性”疾病,但对于这一适应证接受 C+IRA 的患者与接受其他非炎症性良性疾病手术的患者相比,其发病率显著增加。